Advancing prevention, diagnosis and treatment research for the 30 million people living with a rare disease in Europe.
Connected for impact:
2nd International Conference on Clinical Research Networks
9 & 10 December 2025
-scaled.png "MS Teams webinar banner (1)")
ERDERA Funding
The 2026 Joint Transnational Call
Pre-Announcement is now live!
LATEST
News & Updates
World Orphan Drug Congress USA 2026
ERDERA
Research Services
our mission
Goals & Impacts
Unify knowledge, resources and expertise
ERDERA brings under one roof a broad range of high-value services, resources and cross-disciplinary expertise to support rare disease research projects across Europe, from planning and design to efficient execution.
Boost clinical research with and for patients
Enabling every consenting patient living with a rare disease to be findable and enrolled in a suitable clinical study that matches their needs and preferences is a core goal in ERDERA. Empowered patients can contribute to the generation of high-quality evidence to improve diagnosis, understanding of diseases and develop treatments.
Spur innovation and EU competitiveness
The new partnership aims to make Europe a global leader in rare disease research by increasing investment to spur innovation, aligning regional, national and European research strategies, and fostering collaboration among all stakeholders at global scale.
Upcoming Events
Join the 2nd International Conference on Clinical Research Networks: Connected for impact!
Gathering key stakeholders, including EU policymakers, industry leaders, patient advocacy groups, researchers, and healthcare providers. Its goal is to identify concrete actions and incentives to enhance innovation across the rare disease ecosystem.
Presenting key achievements of RDCA-DAP in building a multi-disease rare disease database.
This information webinar on the 2026 Joint Transnational Call for Proposals is scheduled for 16 December 2025, 15:00–17:00 CET, focusing on resolving unsolved rare genetic and non‑genetic diseases.
The next ECRD will take place on 3–4 June 2026 in Prague under the title “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”.
More than 280 speakers from industry, regulators, patient organisations, investors and healthcare providers, and aims to showcase new science, technologies and policies that can accelerate orphan drug development and improve access to therapies for people living with rare conditions.
NEWSLETTER
Keep connected through ERDERA
Community voices, fresh funding calls, news, events, training opportunities and accessible resources — delivered straight to your inbox, ready when you are!